What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary areas of study are Neuroscience, Depression, Dorsolateral prefrontal cortex, Prefrontal cortex and Psychiatry.
His Depression research incorporates elements of Vagus nerve stimulation and Brain mapping.
Malek Bajbouj has included themes like Stimulation, Transcranial direct-current stimulation and Audiology in his Dorsolateral prefrontal cortex study.
He usually deals with Audiology and limits it to topics linked to Cognition and International Affective Picture System, Arousal and Cognitive psychology.
His Prefrontal cortex research is multidisciplinary, relying on both Major depressive disorder, Anxiety, Frontal lobe and Amygdala.
His biological study spans a wide range of topics, including Internal medicine and Polymorphism.
His most cited work include:
- Association of a functional BDNF polymorphism and anxiety-related personality traits (244 citations)
- Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing (158 citations)
- Vagus nerve stimulation for depression: efficacy and safety in a European study. (139 citations)
What are the main themes of his work throughout his whole career to date?
Malek Bajbouj focuses on Neuroscience, Depression, Psychiatry, Internal medicine and Major depressive disorder.
His study in Neuroscience focuses on Prefrontal cortex, Transcranial magnetic stimulation, Dorsolateral prefrontal cortex, Stimulation and Working memory.
The study incorporates disciplines such as Developmental psychology and Anterior cingulate cortex in addition to Prefrontal cortex.
His studies examine the connections between Depression and genetics, as well as such issues in Anesthesia, with regards to Pharmacotherapy.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Cardiology.
His work in Major depressive disorder covers topics such as Antidepressant which are related to areas like Beck Depression Inventory and Clinical trial.
He most often published in these fields:
- Neuroscience (34.16%)
- Depression (21.40%)
- Psychiatry (18.52%)
What were the highlights of his more recent work (between 2018-2021)?
- Mental health (7.00%)
- Depression (21.40%)
- Antidepressant (16.87%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Mental health, Depression, Antidepressant, Clinical psychology and Cognition.
His Depression research integrates issues from Meta-analysis, Traumatic stress, CINAHL and Anxiety.
His research integrates issues of Dorsolateral prefrontal cortex, Ketamine, Major depressive disorder, Brain activity and meditation and Pharmacology in his study of Antidepressant.
His study in Cognition is interdisciplinary in nature, drawing from both Psychopathology, Beck Depression Inventory, Electroconvulsive therapy and Potential biomarkers.
His Working memory study introduces a deeper knowledge of Neuroscience.
In the field of Neuroscience, his study on Cortex, Posterior cingulate and Prefrontal cortex overlaps with subjects such as Modulation and Network switch.
Between 2018 and 2021, his most popular works were:
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (131 citations)
- Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine. (19 citations)
- Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder. (15 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
Malek Bajbouj mostly deals with Antidepressant, Psychological intervention, Ketamine, Psychiatry and Mental health.
His Antidepressant research incorporates themes from Functional connectivity, Anterior cingulate cortex, Resting state fMRI, Prefrontal cortex and Biomarker.
His research in Ketamine intersects with topics in Major depressive disorder, Treatment-resistant depression, Depression and Clinical trial.
His Treatment-resistant depression study combines topics from a wide range of disciplines, such as Standard treatment, Internal medicine, Double blind and Anxiety.
He studied Psychiatry and Sociocultural evolution that intersect with Psychosocial.
The Anesthesia study combines topics in areas such as Neurocognitive, Effects of sleep deprivation on cognitive performance, Cognition and Electroconvulsive therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
